A clinical trial at UCLA is currently investigating the risks of developing an allergic reaction from the COVID-19 vaccines. (Kanishka Mehra/Photo editor)
An ongoing clinical trial at UCLA is investigating the risk of developing an allergic reaction from a COVID-19 vaccine.
The goal of the study is to identify the risk factors for having a systemic allergic reaction – when an allergic reaction spreads from one organ to other areas of the body – from the Pfizer-BioNTech and Moderna COVID-19 vaccines, said Maria Garcia-Lloret, a professor of pediatrics, allergy and immunology.
Los Angeles County moved into the least restrictive tier of California’s reopening plan Tuesday, which will allow some businesses to operate at a higher capacity and open for increased indoor operations.
UCLA researchers found that patients received fewer colonoscopies and more noninvasive colorectal screening tests after May during the COVID-19 pandemic.
According to a study published by UCLA researchers, the number of colonoscopies performed in the UCLA Health system during the COVID-19 pandemic fell from about 222 colonoscopies per week to about 11 per week while hospitals ceased elective endoscopies.
This post was updated May 2 at 9:07 p.m.
UCLA administrators announced plans to hold large fall quarter classes remotely and require vaccination for in-person classes at a town hall Monday.
Los Angeles County could enter the least restrictive tier in California’s reopening plan in the next week, county officials announced Tuesday.
The Los Angeles County Department of Public Health said in a statement Tuesday that the adjusted COVID-19 case rate in Los Angeles County dropped from 2.7 new cases to 1.9 new cases per 100,000 people.
Black and Indigenous panelists emphasized the importance of cultural literacy in public health at a University of California systemwide conference Saturday.
The 11th annual UC Global Health Day focused on the theme of decolonizing global health to advance health equity.
This post was updated April 26 at 7:52 p.m. with a statement from UCLA Health.
Los Angeles County will end an 11-day pause on the Johnson & Johnson COVID-19 vaccine and resume administering the vaccine Saturday after federal health agencies recommended to continue administering the vaccine.
UCLA professors and students are optimistic about the increased vaccination rates in Los Angeles County, but think minority groups have been disproportionately affected by the COVID-19 pandemic.
Genetically engineered stem cells could be used to create a longer lasting and more efficient gene therapy to treat – and potentially cure – HIV infections, a UCLA study found.
searching for more articles...